Mike Gore, Ph.D. '09, professor of plant breeding and genetics, is working on a more efficient way to develop crops that produce higher yields and better nutrition profiles as the world's population grows.
World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 to present the latest discoveries in the study and treatment of Alzheimer's disease.
Cross-campus gathering will focus on the biggest challenges facing the world, and help determine a theme on which the university will focus in the 2019-2020 academic year.
Most Americans underestimate just how concerned minorities and lower-income people are about environmental threats, according to a new study. In fact, those groups are consistently among the most worried about environmental challenges.
As therapies for HIV have advanced to help many patients control the infection as a chronic disease, investigators and patients have set their sights on a new goal: finding a cure. Drs. Douglas Nixon and Brad Jones have recently joined Weill Cornell Medicine in the hopes of accelerating that hunt.
The new GateWay to Partnership program, run out of the Office of Sponsored Programs, aims to foster sponsored agreements between industry and Cornell researchers.
Researchers in the lab of Charles Danko have developed a new tool to study genetic “switches” active in glioblastoma tumors that drive growth of the cancer.
